Integrated Preclinical & Metabolic Optimization of NK Cells Derived from Pluripotent Stem Cells & Peripheral Blood

  • Comparative characterization of iPSC- and peripheral blood–derived NK cells to define intrinsic phenotypic and metabolic differences
  • Functional evaluation of cytotoxicity, persistence, and metabolic adaptability to reveal donor- and source-dependent performance variability
  • Metabolic engineering strategies to enhance mitochondrial fitness, delay exhaustion, and improve next-generation NK cell efficacy